Study of Lenalidomide to Evaluate Safety and Effectiveness in Patients With Diffuse Large B-Cell Lymphoma (DLBCL)
Status:
Completed
Trial end date:
2018-04-05
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare lenalidomide to a control drug and see which one
delays Diffuse Large B-Cell Lymphoma (DLBCL) disease progression longer.